Bhinneka News Online: Reuters Health Report: May 5, 2017

Friday, 5 May 2017

Reuters Health Report: May 5, 2017

Click to View in Browser

Friday, May 5, 2017

House Republicans repeal Obamacare, hurdles await in U.S. Senate

WASHINGTON (Reuters) - The U.S. House of Representatives on Thursday narrowly approved a bill to repeal Obamacare, handing Republican President Donald Trump a victory that could prove short-lived as the healthcare legislation heads into a likely tough battle in the Senate.

Health insurers focused on 2018 unknowns for Obamacare market

NEW YORK (Reuters) - While attention is focused on Republicans' fight to pass a bill to repeal Obamacare starting in 2019, health insurers are busy struggling with decisions they need to make now about how to price premiums and what markets they can afford to be in next year.

Eating pure oats may be okay for celiac sufferers

(Reuters Health) - People with celiac disease have to avoid most grains, but oats may be an exception that's safe, according to a recent research review, so long as the oats are uncontaminated by traces of other grains.

WHO to help bring cheap biosimilar cancer drugs to poor

LONDON (Reuters) - The World Health Organization (WHO) is to launch a pilot project this year to assess cheap copies of expensive biotech cancer drugs in a bid to make such medicines more widely available in poorer countries.

J&J ordered to pay $110 million in U.S. talc-powder trial

(Reuters) - Johnson & Johnson on Thursday was ordered by a Missouri jury to pay over $110 million to a Virginia woman who says she developed ovarian cancer after decades of using of its talc-based products for feminine hygiene.

Prescribing video games for kids with sensory and attention problems

(Reuters Health) - The right kind of video game might one day help improve attention skills in some kids with sensory disorders that make it hard to process what they see and hear, a small experiment suggests.

U.S. prescription drug spending as high as $610 billion by 2021: report

(Reuters) - Spending on prescription medicines in the United States will increase 4-7 percent through 2021, reaching $580 billion to $610 billion, according to a report released by QuintilesIMS Holding on Thursday that lowered its prior long-term forecast.

Novartis, Roche back French gene therapy start-up Vivet

(Reuters) - French gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with backing from the venture arms of Swiss drugmakers Novartis and Roche.

Australia wins landmark WTO tobacco packaging case - Bloomberg

GENEVA/LONDON (Reuters) - A landmark Australian law on restrictive tobacco packaging has been upheld at the World Trade Organization after a five-year legal battle, Bloomberg news reported on Thursday, citing two people familiar with the situation.

Many women don't make 'quality' decisions about breast reconstruction

(Reuters Health) - Most women with breast cancer don't make decisions about surgical reconstruction that are based on knowledge and in line with their own preferences, suggests a small U.S. study.